Your Messages Inbox
Your Article Summary
See Latest ArticlesFour H1N1 influenza vaccines licensed by FDA
American Pharmacists Association, 09/21/09
FDA has licensed four vaccines against 2009 novel H1N1 influenza virus, including products from CSL, MedImmune, Novartis Vaccines and Diagnostics, and sanofi Pasteur. Testifying before a House committee, HHS Secretary Kathleen Sebelius said that small amounts of the products could be available as early as the first full week in October.
Related Articles
Comparison of 18F-Fluoro-L-DOPA, 18F-Fluoro-Deoxyglucose, and 18F-Fluorodopamine PET and 123I-MIBG Scintigraphy in the Localization of Pheochromocytoma and Paraganglioma
Journal of Clinical Endocrinology and Metabolism, 11/12/09
Relevance Score: 89%
A brave new beef: The US food and drug administrations review of the safety of cloned animal products
Gender Medicine, 10/26/09
Relevance Score: 89%
FDA Steps Up Efforts to Find, Remove Violators of Clinical Trial Regulations
JAMA, 10/28/09
Relevance Score: 87%
Angiotech Pharmaceuticals Provides Update on Bio-Seal™ 510(K) Submission
Angiotech Pharmaceuticals, 10/20/09
Relevance Score: 87%
The FDA Reviews Safety of Stimulant Medication for ADHD
American Journal of Nursing, 10/01/09
Relevance Score: 87%
Today in Drug/Product Approvals...keeping you current
Receive free subspecialty "5-minute updates" via email
Novartis receives approval in the European Union for Onbrez Breezhaler, a new once-daily bronchodilator for patients with COPD
Novartis, 12/04/09
Safety concerns slow new drug review and approval processes
Formulary , 12/02/09
Teva Announces The Submission Of A Biologics License Application (BLA) For XM02 For The Treatment Of Chemotherapy-Induced Neutropenia
Teva Pharmaceutical Industries, 12/02/09
Article Search
Sponsor